 |
Happiness Biotech Group Limited
HAPP
|
6.4 M |
- |
1.35 % |
$ 17.8 M |
China |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M |
- |
- |
$ 2.02 B |
USA |
 |
AgeX Therapeutics
AGE
|
3.56 M |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
412 M |
- |
- |
$ 866 M |
China |
 |
Corner Growth Acquisition Corp.
COOL
|
30.2 K |
- |
-0.89 % |
$ 114 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
100 M |
- |
- |
$ 2.18 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B |
- |
- |
$ 40.3 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
42 M |
- |
- |
$ 2.17 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Athira Pharma
ATHA
|
47.5 M |
- |
- |
$ 269 M |
USA |
 |
Galera Therapeutics
GRTX
|
645 K |
- |
-32.59 % |
$ 7.61 M |
USA |
 |
Geron Corporation
GERN
|
112 M |
$ 1.42 |
-2.07 % |
$ 947 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M |
- |
- |
- |
Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M |
- |
- |
$ 231 M |
USA |
 |
Inhibikase Therapeutics
IKT
|
8.3 M |
$ 2.33 |
- |
$ 229 M |
USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M |
- |
-1.58 % |
$ 28.1 M |
China |
 |
Berkeley Lights
BLI
|
45.5 M |
- |
-7.31 % |
$ 87 M |
USA |
 |
Generation Bio Co.
GBIO
|
35.1 M |
- |
- |
$ 344 M |
USA |
 |
Akero Therapeutics
AKRO
|
39.8 M |
- |
- |
$ 3.67 B |
USA |
 |
Akouos
AKUS
|
16.8 M |
- |
0.23 % |
$ 488 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M |
- |
- |
$ 7.46 M |
Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M |
- |
-4.36 % |
$ 27 M |
USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
31 M |
- |
- |
$ 384 M |
Britain |
 |
Gracell Biotechnologies
GRCL
|
221 M |
- |
- |
$ 3.37 B |
China |
 |
Jaguar Health
JAGX
|
40.7 M |
$ 0.96 |
-6.48 % |
$ 2.24 M |
USA |
 |
Johnson & Johnson
JNJ
|
54.1 B |
$ 263.4 |
1.58 % |
$ 634 B |
USA |
 |
Advaxis
ADXS
|
25 M |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Alkermes plc
ALKS
|
543 M |
$ 52.89 |
-0.15 % |
$ 8.71 B |
Irlanda |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M |
- |
- |
$ 26.5 M |
USA |
 |
Achieve Life Sciences
ACHV
|
9.08 M |
$ 6.1 |
-1.13 % |
$ 266 M |
USA |
 |
Aptose Biosciences
APTO
|
9.31 M |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Aptinyx
APTX
|
6.29 M |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Albireo Pharma
ALBO
|
45.3 M |
- |
-0.23 % |
$ 916 M |
USA |
 |
AlloVir
ALVR
|
9.71 M |
- |
4.14 % |
$ 49.1 M |
USA |